Advil Liqui Gels (minis), Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Pfizer, Madison, NJ 07940, UPC 3 0573 1769 13 5
Published February 1, 2023 · Recall initiated: December 6, 2022
Summary
FDA records drug Class I recall D-0183-2023, published February 1, 2023 and initiated December 6, 2022. Recalling firm: Glaxosmithkline Consumer Healthcare Holdings DBA Haleon; Status: Terminated; Reported quantity: 209,292 capsules; Lot: Lot: R93517, R94072, R94073, Exp 02/29/2024; T00655, Exp 03/31/2025. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Glaxosmithkline Consumer Healthcare Holdings DBA Haleon
- Distributor
- Nationwide in the USA.
- Lot
- Lot: R93517, R94072, R94073, Exp 02/29/2024; T00655, Exp 03/31/2025
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAdvil Liqui Gels, Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquidFebruary 1, 2023
- FDAAdvil (ibuprofen) Tablets, 200 mg, packaged as a) 360-count bottles (UPC 3 0573 0154 60 4), and b) 200-countFebruary 1, 2023
- FDAVancomycin Hydrochloride for Injection, USP, 1.5 g/vial, Sterile powder, Single-dose Fliptop Vial, 10 vialsFebruary 1, 2023
- FDADutasteride 0.1% (1.5ML VIAL) Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.February 1, 2023
- FDAEpinephrine (L-Adrenaline), USP, CAS 51-43-4, Packaged in amber glass bottles in a vacuum sealed pouch asFebruary 1, 2023
- FDAChlorpheniramine/Hyoscyamine (1ML) 10MG/0.25MG/ML Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St.,February 1, 2023
Questions about this recall
Was Advil Liqui Gels (minis), Solubilized ibuprofen capsules, 200mg, Pain Reliever Fever Reducer (NSAID), 200 liquid filled capsules, Pfizer, Madison, NJ 07940, UPC 3 0573 1769 13 5 recalled?
Yes. FDA published recall D-0183-2023 on February 1, 2023. Reported hazard: Labeling: Illegible Label; the adhesive migrated onto a portion of the label, causing it to tear when peeled back
What should I do if I have this product?
Voluntary: Firm initiated · Letter